157 related articles for article (PubMed ID: 12617408)
1. Hypercalcaemia.
Selby P
Clin Med (Lond); 2003; 3(1):19-22. PubMed ID: 12617408
[No Abstract] [Full Text] [Related]
2. The patient with hypercalcaemia.
Heath D
Practitioner; 2002 Jan; 246(1630):44-9. PubMed ID: 11816418
[No Abstract] [Full Text] [Related]
3. Approach to the Child with Hypercalcaemia.
Davies JH
Endocr Dev; 2015; 28():101-118. PubMed ID: 26138838
[TBL] [Abstract][Full Text] [Related]
4. Thyrotoxic hypercalcaemia treated with porcine calcitonin.
Buckle RM; Mason AM; Middleton JE
Lancet; 1969 Jun; 1(7606):1128-30. PubMed ID: 4181605
[No Abstract] [Full Text] [Related]
5. [Pathophysiology and treatment of malignancy-associated hypercalcemia].
Miyauchi A
Nihon Rinsho; 2006 Jun; Suppl 2():161-4. PubMed ID: 16817374
[No Abstract] [Full Text] [Related]
6. Clinical practice. Asymptomatic primary hyperparathyroidism.
Bilezikian JP; Silverberg SJ
N Engl J Med; 2004 Apr; 350(17):1746-51. PubMed ID: 15103001
[No Abstract] [Full Text] [Related]
7. The management of hypercalcaemia in advanced cancer.
Pettifer A; Grant S
Int J Palliat Nurs; 2013 Jul; 19(7):327-31. PubMed ID: 24273809
[TBL] [Abstract][Full Text] [Related]
8. [Hypercalcemia (with treatment)].
Prié D
Rev Prat; 2006 Oct; 56(16):1827-33. PubMed ID: 17315511
[No Abstract] [Full Text] [Related]
9. Comparison of low-dose intramuscular and intravenous salcatonin in the treatment of primary hyperparathyroidism.
Stone MD; Marshall DH; Hosking DJ; Garcia-Himmelstine C; White DA; Worth HG
Bone; 1992; 13(3):265-71. PubMed ID: 1637574
[TBL] [Abstract][Full Text] [Related]
10. Hypercalcaemia. Management.
Selby PC; Peacock M; Marshall DH
Br J Hosp Med; 1984 Mar; 31(3):186, 188, 190 passim. PubMed ID: 6324944
[No Abstract] [Full Text] [Related]
11. [Therapy of hypercalcemia with ibandronate in case of acute renal failure].
Bergner R; Henrich DM; Hoffmann M; Bruckner D; Uppenkamp M
Internist (Berl); 2006 Mar; 47(3):293-6. PubMed ID: 16470360
[TBL] [Abstract][Full Text] [Related]
12. Acquired hypocalciuric hypercalcemia due to autoantibodies against the calcium-sensing receptor.
Pallais JC; Kifor O; Chen YB; Slovik D; Brown EM
N Engl J Med; 2004 Jul; 351(4):362-9. PubMed ID: 15269316
[No Abstract] [Full Text] [Related]
13. The diagnosis and management of hypercalcaemia.
Koh LK
Ann Acad Med Singap; 2003 Jan; 32(1):129-39. PubMed ID: 12625112
[TBL] [Abstract][Full Text] [Related]
14. Severe symptomatic hypercalcaemia.
Calvo-Romero JM; Bonilla-Gracia MC
Postgrad Med J; 2000 Oct; 76(900):662; 668. PubMed ID: 11009589
[No Abstract] [Full Text] [Related]
15. How to approach hypercalcaemia.
Crowley R; Gittoes N
Clin Med (Lond); 2013 Jun; 13(3):287-90. PubMed ID: 23760705
[TBL] [Abstract][Full Text] [Related]
16. The diagnosis of hyperparathyroidism (or what to do until the immunoassay comes).
Raisz LG
N Engl J Med; 1971 Oct; 285(18):1006-10. PubMed ID: 4937688
[No Abstract] [Full Text] [Related]
17. Severe hypercalcaemia of primary hyperparathyroidism: Could giant adenoma be the real culprit rather than carcinoma?
Gücek Haciyanli S; Acar N; Gür EÖ; Çelik SC; Karaıslı S; Dilek ON; Haciyanli M
Ann R Coll Surg Engl; 2020 May; 102(5):363-368. PubMed ID: 32233846
[TBL] [Abstract][Full Text] [Related]
18. Evaluation and therapy of hypercalcemia.
Khoury N; Carmichael KA
Mo Med; 2011; 108(2):99-103. PubMed ID: 21568230
[TBL] [Abstract][Full Text] [Related]
19. [Hypercalcemia].
Matikainen N
Duodecim; 2014; 130(14):1404-12. PubMed ID: 25158579
[TBL] [Abstract][Full Text] [Related]
20. Early biochemical response to parathyroidectomy for primary hyperparathyroidism and its predictive value for recurrent hypercalcemia and recurrent primary hyperparathyroidism.
Ryder CY; Jarocki A; McNeely MM; Currey E; Miller BS; Cohen MS; Gauger PG; Hughes DT
Surgery; 2021 Jan; 169(1):120-125. PubMed ID: 32768241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
